Log in

Relevant bibliographies by topics / Bladder cancer / Books

Books on the topic 'Bladder cancer'

To see the other types of publications on this topic, follow the link: Bladder cancer.

Author: Grafiati

Published: 4 June 2021

Last updated: 8 June 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Bladder cancer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Droller, Michael J. Bladder Cancer. New Jersey: Humana Press, 2001. http://dx.doi.org/10.1385/1592590977.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kamat, Ashish M., and Peter C. Black, eds. Bladder Cancer. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-70646-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Lee, Cheryl T., and David P. Wood, eds. Bladder Cancer. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-59745-417-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Zingg, E. J., and D. M. A. Wallace, eds. Bladder Cancer. London: Springer London, 1985. http://dx.doi.org/10.1007/978-1-4471-1362-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Lerner, Seth P., Mark P. Schoenberg, and Cora N. Sternberg, eds. Bladder cancer. Chichester, UK: John Wiley & Sons, Ltd, 2015. http://dx.doi.org/10.1002/9781118674826.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

J, Zingg Ernst, and Wallace, D. M. A. 1946-, eds. Bladder cancer. Berlin: Springer-Verlag, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

1948-, Bailey Michael, ed. Bladder cancer. 2nd ed. Abingdon: Health, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

W, Kantoff Philip, and Scher Howard I, eds. Bladder cancer. Philadelphia: Saunders, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

D, Oliver R. T., and Coptcoat Malcolm J, eds. Bladder cancer. Plainview, N.Y: Cold Spring Harbor Laboratory Press, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Campaign, Cancer Research. Bladder cancer - UK. [London]: Cancer Research Campaign, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Bassi, PierFrancesco, and Francesco Pagano, eds. Invasive Bladder Cancer. London: Springer London, 2007. http://dx.doi.org/10.1007/978-1-84628-377-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Pierfrancesco, Bassi, Fair William R, and Pagano Francesco, eds. Superficial bladder cancer. Oxford: Isis Medical Media, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Konety, Badrinath R., and Sam S. Chang, eds. Management of Bladder Cancer. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-1881-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Soria, Francesco, and Paolo Gontero, eds. Treating Urothelial Bladder Cancer. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-78559-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

National Cancer Institute (U.S.) and National Institutes of Health (U.S.), eds. Cancer of the bladder. Bethesda, MD]: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Bock, Robert. Cancer of the bladder. [Bethesda, MD]: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Derek, Raghavan, ed. The Management of bladder cancer. London: Edward Arnold, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Cooke, Peter William. CD40 expression in bladder cancer. Birmingham: University of Birmingham, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

1939-, Hall Reginald R., ed. Clinical management of bladder cancer. London: Arnold, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

J, Droller Michael, ed. Bladder cancer: Current diagnosis and treatment. Totowa, N.J: Humana Press, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Raghavan, Derek. The Cleveland Clinic guide to bladder cancer. New York, NY: Kaplan Pub., 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

N, Syrigos Konstantinos, and Skinner Donald G, eds. Bladder cancer: Biology, diagnosis, and management. Oxford: Oxford University Press, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

National Cancer Institute (U.S.), ed. What you need to know about bladder cancer. 2nd ed. [Bethesda, Md.?]: National Institutes of Health, National Cancer Institute, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Lee, Cheryl T. Bladder cancer: Diagnosis, therapeutics, and management. New York, NY: Humana Press, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Humberto, Villavicencio, and Fair William R, eds. Evaluation of chemotherapy in bladder cancer. Edinburgh: Churchill Livingstone, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Zingg, E. J., and D. M. A. Wallace. Bladder Cancer. Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Silverman, Debra T., Stella Koutros, Jonine D. Figueroa, Ludmila Prokunina-Olsson, and Nathaniel Rothman. Bladder Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0052.

Full text

Abstract:

In the United States, an estimated 74,000 new cases of bladder cancer and 16,000 deaths occur annually. Because of favorable survival, approximately 578,000 persons are alive after diagnosis. Recurrence after treatment is common, necessitating lifelong surveillance and care, making bladder cancer the most costly malignancy from diagnosis to death. The median age at diagnosis has increased from 67 years in 1980 to 73 years in 2008–2012. Incidence rates rise dramatically with age, suggesting that as the US population ages, the burden of bladder cancer in the United States will continue to grow. Worldwide over 1.3 million cases are estimated to occur annually. Cigarette smoking is the principal known cause of bladder cancer, along with various chemical exposures. Recent studies suggest that, over the past two decades, the risk for current smokers has increased from three times the risk of nonsmokers to about four to five times the nonsmoker risk.

APA, Harvard, Vancouver, ISO, and other styles

28

Bladder Cancer. Elsevier, 2018. http://dx.doi.org/10.1016/c2015-0-06215-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

James, Nicholas, Elizabeth Southgate, and Anjali Zarkar. Bladder cancer. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199696567.003.0010.

Full text

Abstract:

Chapter 8b discusses the considerable controversy as to the optimal management of localized, muscle invasive bladder cancer. Surgical removal of the bladder is considered the ‘gold standard’ in many countries but there is no randomized trial to underpin this statement, and many patients are unfit for surgery. Reported 5-year survival rates with radiotherapy are remarkably similar to surgical series. Thus even if surgery is genuinely better than radiotherapy for patients fit for both approaches, there are many patients for whom radical surgery is simply not suitable and hence bladder-preserving techniques are appropriate.

APA, Harvard, Vancouver, ISO, and other styles

30

Meijer, Richard P., Alexandre R. Zlotta, and Bas W. G. van Rhijn. Bladder cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0077.

Full text

Abstract:

High-grade non-muscle-invasive bladder cancer (HG-NMIBC) represents the most aggressive spectrum of this non-invasive cancer. This collective term includes all high-grade NMI urothelial carcinoma (UC), such as those without invasion (pTa), those with lamina propria invasion (pT1), and those that are only/have concomitant carcinoma in situ (CIS; pTis). These cancers have a high risk for intravesical recurrence (around 46–78% at five years) and progression (between 6–45% at five years) to muscle-invasive bladder cancer (MIBC). As with all UC, their presentation can be with visible haematuria or irritative lower urinary tract symptoms. The latter are common in patients with CIS. CIS may be detected in isolation (so-called primary CIS) or with a coexisting UC elsewhere (termed concomitant CIS). While urinary cytology has a moderate sensitivity and high specificity (>90%) for the detection of HG-NMIBC, cystoscopy is the most important diagnostic tool.

APA, Harvard, Vancouver, ISO, and other styles

31

Bladder Cancer. Totowa: Humana Press, Inc, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Ku, Ja Hyeon. Bladder Cancer. Elsevier Science & Technology Books, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Zingg, E. J., and D. M. A. Wallace. Bladder Cancer. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

Bladder Cancer. Lippincott Williams & Wilkins, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

Bladder Cancer. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Lee, Cheryl T., and David P. Wood. Bladder Cancer. Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Ku, Ja Hyeon. Bladder Cancer. Elsevier Science & Technology Books, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Mayr, Roman, and Maximilian Burger. Squamous cell bladder cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0080.

Full text

Abstract:

In the developed countries, over 90% of the bladder cancer cases are transitional cell carcinoma (TCC), with squamous cell carcinoma (SCC), adenocarcinomas, and rare types of bladder cancer comprising the remaining 10% of bladder cancer cases. In Western regions, pure SCC of the bladder constitutes 1.2–4.5% of all bladder tumours. SCC can occur in both non-bilharzial and bilharzial bladders; the two subtypes differ in epidemiology, pathogenesis, and clinical outcome. Squamous cell carcinoma in the bilharzial bladder is an endemic disease in many regions of the Middle East, Africa, Southeast Asia, and South America. The knowledge of SCC of the bladder is nevertheless important due to different aetiology, clinical pathways, and clinical outcome.

APA, Harvard, Vancouver, ISO, and other styles

39

Kogevinas, Manolis, Jonine Figueroa, Montserrat Garcia-Closas, and Lorelei Mucci. Urinary Bladder Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190676827.003.0022.

Full text

Abstract:

Bladder cancer is the ninth most common cancer worldwide, resulting in 430,000 new cases in 2012, and its incidence is substantially higher in men than women. Urothelial cell carcinoma, also known as transitional cell carcinoma, is the predominant histopathologic type. Bladder cancer occupies an important place in occupational epidemiology, in which associations with occupations exposed to aromatic amines were first identified in the 1950s. It is also among the first cancers for which an infectious etiology was identified, through parasitic infection with Schistosoma haematobium, which occurs in Africa and the eastern Mediterranean. Smokers have a two- to threefold increased risk of bladder cancer, and a fivefold higher risk for heavy smokers. Specific medical conditions, including urinary stones and diabetes, are positively associated with risk. Finally, bladder cancer is one of the few examples with consistent evidence of interactions between environmental exposures and genetic polymorphisms in cancer epidemiology.

APA, Harvard, Vancouver, ISO, and other styles

40

Chapman, Hannah, and Christine Elwell. Renal and bladder cancer. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0167.

Full text

Abstract:

This chapter addresses the diagnosis and management of bladder and renal cancers. In the UK, bladder cancer is the fourth most common cancer in men, and the eighth most common cancer in women. Bladder cancer arises from the bladder urothelium, and is typically a papillary transitional cell carcinoma. Chronic infection with the parasite Schistosoma haematobium is associated with squamous cell carcinoma of the bladder, and is most prevalent in Egypt and sub-Saharan Africa. Renal cancer accounts for 3% of cancers in adults in the UK and, in most cases, is a renal cell carcinoma arising from proximal renal tubule epithelium. A further 5%–10% of renal cancers are transitional cell (urothelial) carcinomas of the renal pelvis. Benign kidney tumours, such as cysts, are also common.

APA, Harvard, Vancouver, ISO, and other styles

41

Pagano, Francesco, and Pierfrancesco Bassi. Invasive Bladder Cancer. Springer, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Maisel, Leslie Blumgart, William Jarnegan, Yuman Fong, Francesco Pagano, and Bassi. Invasive Bladder Cancer. Routledge, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Pagano, Francesco, and Pierfrancesco Bassi. Invasive Bladder Cancer. Springer, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Bassi. Invasive Bladder Cancer. ISIS Medical Media, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Fair, William R. Superficial Bladder Cancer. Taylor & Francis, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Chamberlain, J. Desmond Baggot, Eric Marcus, Stephen R. Baker, Jon C. Thompson, Kimmel, Michael Polis, et al. Invasive Bladder Cancer. Humana Press, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

(Editor), PierFrancesco Bassi, and Francesco Pagano (Editor), eds. Invasive Bladder Cancer. Springer, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Clinical Bladder Cancer. Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

49

Pavone-Macaluso, Michele. Clinical Bladder Cancer. Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

50

Pagano, Marcello. Invasive Bladder Cancer. Not Avail, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!